Quick Answer
Regencell Bioscience Holdings Ltd reported Net Income of -$3.58 million for fiscal year 2025.
Regencell Bioscience Holdings Ltd Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$3.58M | +16.7% |
| 2024 | -$4.30M | +26.7% |
| 2023 | -$5.87M | +21.1% |
| 2022 | -$7.45M | -452.9% |
| 2021 | -$1.35M | -65.8% |
| 2020 | -$812.4K | -107.8% |
| 2019 | -$391.0K | — |
- Regencell Bioscience Holdings Ltd showed an increase of +16.7% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Regencell Bioscience Holdings Ltd’s net income has declined by 816.7% (from -$391.0 thousand to -$3.58 million).
- The most recent figure is from Regencell Bioscience Holdings Ltd’s fiscal year 2025 report (Form 20-F), filed with the SEC on October 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: